Aquestive Therapeutics (AQST) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Aquestive Therapeutics (AQST) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | -3.06 |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 7.27 |
| 10 | Aquestive Therapeutics | 638.72 Mn | 540.23 Mn | 9.80 Mn | -0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | -0.30 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.13 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | 0.11 |
| Dec 31, 2022 | -0.25 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.36 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.76 |
| Sep 30, 2021 | -0.37 |